Next Article in Journal
Development and In Vitro Evaluation of a Mucoadhesive Oral Deliverv System for Antisense Oliaonucleotides
Previous Article in Journal
Analysis of flavonoids in Achillea nobilis L. bv capillarv electrophoresis
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Mass uniformity of nasal sprays

Nina Grobuschek
Oliver Lecnik
Martin G. Schmid
Gerald Gubitz
Institute of Pharmaceutical Chemistry and Pharmaceutical Technology, Karl-Franzens University, Universitatsplatz 1, A-801 0 Graz, Austria
Author to whom correspondence should be addressed.
Sci. Pharm. 2003, 71(3), 151-164;
Submission received: 5 June 2003 / Revised: 23 June 2003 / Accepted: 23 June 2003 / Published: 28 June 2003


The uniformity of nasal spray dose delivery was investigated. Four selected nasal sprays commercially available on the European market were checked for their mass uniformity according to the guidelines of the European Pharmacopoeia and recent draft guidelines of the Food and Drug Administration (FDA). Mass uniformity was also determined with simulation of a patient's use daily, and at 3- and 7- day intervals. The influence of the degree of filling and different storage positions on mass uniformity were also investigated. At first usage, all preparations fulfilled the specifications of the Ph.Eur. and the FDA draft guidelines. When patient application was simulated, however, the dose accuracy decreased significantly with some of the preparations with increasing time of non-usage, presumably due to evaporation of liquid in the application system. This is indicated by a loss of weight of the nasal spray flasks observed during simulated weekly usage. Under these conditions (6 days' storage without use, same demands for uniformity of mass of the delivered dose), one of the preparations even failed to meet the Ph.Eur. and FDA limits.
Keywords: Nasal sprays; Mass uniformity Nasal sprays; Mass uniformity

Share and Cite

MDPI and ACS Style

Grobuschek, N.; Lecnik, O.; Schmid, M.G.; Gubitz, G. Mass uniformity of nasal sprays. Sci. Pharm. 2003, 71, 151-164.

AMA Style

Grobuschek N, Lecnik O, Schmid MG, Gubitz G. Mass uniformity of nasal sprays. Scientia Pharmaceutica. 2003; 71(3):151-164.

Chicago/Turabian Style

Grobuschek, Nina, Oliver Lecnik, Martin G. Schmid, and Gerald Gubitz. 2003. "Mass uniformity of nasal sprays" Scientia Pharmaceutica 71, no. 3: 151-164.

Article Metrics

Back to TopTop